BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Chiltern International Ltd. Welcomes Gastroenterology, Oncology and Pediatric Therapeutic Experts to Their Team


2/1/2012 10:06:26 AM

LONDON, Jan. 31, 2012 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Marcelo Piccirillo and Carlo Lanza have joined Chiltern, bringing their expertise in the areas of gastroenterology, oncology and pediatrics to serve our clients' needs.

"We are delighted to announce the addition of Drs. Marcelo Piccirillo and Carlo Lanza to Chiltern's Medical team. They strengthen our capabilities in the prominent clinical study areas of gastroenterology, oncology and pediatrics," commented Sharon Moore, MD, Executive VP, Global Quality & Medical Affairs, Chiltern. "These are key therapeutic positions and Drs. Piccirillo and Lanza bring a wealth of experience which enhances our operational delivery and consultative approach for our clients."

Marcelo Piccirillo, MD, will serve as Sr. Clinical Research Physician based out of the Wilmington, USA office with special emphasis in developing the gastroenterology therapeutic area. Dr. Piccirillo has 20 years experience in the medical and clinical research industry including 7 years as a general and colorectal surgeon. His extensive clinical research therapeutic experience includes a variety of indications such as gastroenterology, pulmonary (asthma/COPD), oncology, neurology, diabetes, metabolic disease, drug safety and medical monitoring of clinical trials among others. In the past five years Dr. Piccirillo has worked extensively in the areas of Inflammatory Bowel Disease (IBD) and colonic transit disorders.

Carlo Lanza, MD, will serve as Sr. Clinical Research Physician based out of the Milan, Italy office to support and expand Chiltern's global activities in the oncology, hematology and pediatric therapeutic areas. Dr. Lanza has over 20 years of clinical research experience, including more than 10 years in academic medicine and clinical practice. During the last several years Dr. Lanza has served in extensive medical lead roles at large pharma companies and international organizations in the therapeutic areas of oncology, hematology, pediatrics and malaria R & D at a global level, including major clinical leadership activities in emerging markets in Asia and Africa.

Dr. Piccirillo is board-certified in General Surgery from the Hospital Evita, Buenos Aires, Argentina and completed a colorectal surgery fellowship at Cleveland Clinic Florida, USA with a special focus on IBD, colorectal cancer and other colonic transit disorders.

Dr. Lanza received MD and PhD degrees from the University of Turin, Italy with Italian board certification in pediatrics and completed an MSc in Hematology at the University of London. He is a member of the Italian Medical Order, the General Medical Council (GMC) UK and American Society of Hematology (ASH).

Both physicians are widely-published.

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs nearly 1,300 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.

For More Information Contact:

Natalie Chong

Susan Ojanen

Marketing Director

Marketing Executive

Chiltern International Ltd.

Chiltern International Inc.

171 Bath Road

1241 Volunteer Parkway

Slough

Suite 950

Berkshire SL1 4AA

Bristol, TN 37620

UNITED KINGDOM

USA

Tel: +44 (0) 1753 512 000

Tel: +1 (423) 968 9533

Fax: +44 (0) 1753 511 116

Fax: +1 (423) 968 3567

Email: natalie.chong@chiltern.com

Email: susan.ojanen@chiltern.com

SOURCE Chiltern


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->